MetLife (MET) Given Coverage Optimism Score of 0.11

News coverage about MetLife (NYSE:MET) has trended somewhat positive this week, Accern Sentiment reports. Accern ranks the sentiment of media coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. MetLife earned a news sentiment score of 0.11 on Accern’s scale. Accern also gave media coverage about the financial services provider an impact score of 46.74990678297 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

These are some of the headlines that may have impacted Accern Sentiment’s analysis:

Shares of MetLife (MET) traded down $0.04 during midday trading on Wednesday, hitting $53.00. 3,500,386 shares of the stock were exchanged, compared to its average volume of 5,728,484. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.16 and a current ratio of 0.16. The stock has a market cap of $55,790.00, a P/E ratio of 10.31, a PEG ratio of 1.35 and a beta of 1.49. MetLife has a 12-month low of $44.26 and a 12-month high of $55.91.

MetLife (NYSE:MET) last announced its quarterly earnings results on Wednesday, November 1st. The financial services provider reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.90 by $0.19. The firm had revenue of $16.10 billion for the quarter, compared to the consensus estimate of $15.47 billion. MetLife had a negative net margin of 0.75% and a positive return on equity of 8.81%. The business’s quarterly revenue was up 1.7% compared to the same quarter last year. During the same quarter last year, the firm posted $1.28 EPS. equities research analysts forecast that MetLife will post 4.43 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 13th. Stockholders of record on Monday, November 6th will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 3.02%. The ex-dividend date of this dividend is Friday, November 3rd. MetLife’s payout ratio is presently 347.83%.

Several research analysts recently issued reports on the stock. Sandler O’Neill lowered shares of MetLife from a “buy” rating to a “hold” rating in a research note on Friday, November 10th. ValuEngine lowered shares of MetLife from a “strong-buy” rating to a “buy” rating in a research note on Thursday, November 9th. Zacks Investment Research upgraded shares of MetLife from a “hold” rating to a “buy” rating and set a $60.00 price target for the company in a research note on Thursday, November 9th. B. Riley reiterated a “neutral” rating on shares of MetLife in a research note on Monday, November 6th. Finally, Argus increased their price target on shares of MetLife from $55.00 to $60.00 and gave the stock a “buy” rating in a research note on Monday, November 6th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company’s stock. MetLife currently has an average rating of “Buy” and a consensus price target of $58.40.

In related news, insider Christopher G. Townsend sold 82,731 shares of the firm’s stock in a transaction that occurred on Friday, November 3rd. The shares were sold at an average price of $54.60, for a total value of $4,517,112.60. Following the transaction, the insider now owns 49,660 shares of the company’s stock, valued at $2,711,436. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Christopher G. Townsend sold 55,712 shares of the firm’s stock in a transaction that occurred on Monday, November 6th. The stock was sold at an average price of $54.29, for a total transaction of $3,024,604.48. Following the completion of the transaction, the insider now directly owns 25,181 shares in the company, valued at approximately $1,367,076.49. The disclosure for this sale can be found here. Company insiders own 0.32% of the company’s stock.

WARNING: “MetLife (MET) Given Coverage Optimism Score of 0.11” was first reported by Community Financial News and is the sole property of of Community Financial News. If you are viewing this piece of content on another publication, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.com-unik.info/2017/12/06/metlife-met-given-coverage-optimism-score-of-0-11.html.

MetLife Company Profile

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Insider Buying and Selling by Quarter for MetLife (NYSE:MET)

What are top analysts saying about MetLife Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for MetLife Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit